More than half of all American adults, almost 137 million people, could be candidates for the blockbuster GLP-1 drug ...

About 140 million Americans, more than half of the nation's adults, could be considered candidates for weight loss drugs ...

As millions patients struggled to fill their prescriptions for the new weight loss drugs, many have turned to compounded copies.

U.S. government health plans account for the lion's share of coverage for popular new weight-loss drugs, far beyond the ...

State Medicaid programs for low-income families are the single biggest source of coverage, giving 31.6 million people access ...

Analysts look at the likelihood of lawmakers making moves to rein in drug middlemen this session. Also, covid-era prescription flexibility is kept in place, pharmaceutical companies take on GLP-1 ...

The mix of coverage can have consequences for Novo and Lilly profits. Medicaid, for instance, is eligible for some of the ...

Ozempic, Wegovy and other GLP-1 drugs have been shown to curb alcoholism, a new study suggests. Researchers explain why ...

In general, when a person prepares for a surgery, the guidance is to fast before going under anesthesia–but for patients, on GLP-1’s there may still be ...

Researchers looked at the health records of 17 million Americans with obesity and determined that between 2022 and 2023, ...

With brand-name GLP-1s for obesity treatment on and off the shortage list, prescribing can get complicated. Five providers ...